14 results
Abdominal Aortic Aneurysm (AAA) Management and Surveillance

- Screening should be considered for more than just men
Aortic Aneurysm (AAA ... Ana Casanegra ... #Management #Aorta ... #Vascular #Treatment ... #Algorithm
Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA) - ANCA Vasculitis Management Algorithm - ACR/VF 2021
Polyangiitis (MPA) - ANCA ... RTX, GC+CYC, GC+AZA ... Polyangiitis #MPA #ANCA ... Vasculitis #Management #Treatment ... #rheumatology
Eosinophilic Granulomatosis with Polyangiitis (EGPA) - ANCA Vasculitis Management Algorithm - ACR/VF 2021 Guidelines
 • Active
Polyangiitis (EGPA) - ANCA ... GC + MTX, GC + AZA ... #Polyangiitis #ANCA ... Vasculitis #Management #Treatment ... #rheumatology
Vasculitis and Vasculitides - Differential Diagnosis Framework

When to Consider Vasculitis:
 • Purpura, ischemic skin lesions
 •
(Granulomatous disease ... < 30 years - Aorta ... branches • GCA: - Aorta ... LFT • ESR • ANA ... differential #diagnosis #rheumatology
Persistent UC Symptoms Despite 5-ASA Therapies
 • Assess for Drug Adherence
 • Disease Activity Assessment (bloody
Symptoms Despite 5-ASA ... Drug Adherence • Disease ... JAK Inhibitor Algorithm ... Waseem_AhmedMD #Ulcerative ... #Management #Algorithm
Mild-to-Moderate Ulcerative Colitis - Management Algorithm
Curcumin:
 • Natural phytochemical from turmeric
 • 2g/day divided in 2-3
Mild-to-Moderate Ulcerative ... Colitis - Management Algorithm ... dosing if liver disease ... Waseem_AhmedMD #Ulcerative ... #treatment #IBD
Polyarteritis Nodosa (PAN) - Vasculitis Management Algorithm - ACR/VF 2021 Guidelines
 • Severe Disease → Remission
Guidelines • Severe Disease ... • Non-Severe Disease ... MTX or AZA) with ... Vasculitis #Management #Treatment ... #rheumatology
Systemic Lupus Erythematosus (SLE) - Diagnosis and Management Summary
 • Epidemiology: 10-180/100,000, Typically Age 20-40, F:M
Workup: - ANA ... 50-60% - pANCA ... life-threatening • Treatment ... Evolution: Chronic disease ... Management #Summary #rheumatology
Systemic Lupus Erythematosus - Summary
Antinuclear (ANA) - 95% - Initial screening test
Anti-dsDNA - 50%
 • Associated
Antinuclear (ANA ... with more severe disease ... Used to monitor disease ... Treatment: • ... Summary #diagnosis #rheumatology
Drug Induced Lupus vs SLE
Drug Induced Lupus (DIL):
 • Epidemiology: -10% of all lupus cases, drug-dependent,
Workup: - ANA ... Workup: - ANA ... life-threatening • Treatment ... Evolution: Chronic disease ... comparison #table #rheumatology